Multiple Sclerosis Journal - Experimental, Translational and Clinical
SAGE Publishing
About the journal
Multiple Sclerosis Journal - Experimental, Translational and Clinical is an open-access journal published by SAGE Publishing in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,650 USD. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- SAGE Publishing
- ISSN
- 2055-2173
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,650 USD
- Articles in DOAJ
- 635
- Declared review time
- 15 weeks
- Declared peer-review model
- peer_review
- Official website
- https://journals.sagepub.com/home/mso
Index listings
- DOAJ · 2016-12-06
- Indexing
- DOAJ
- APC
- 2,650 USD
- Declared review time (DOAJ)
- 15 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
635
Most recent article
last month
Average review time (journal-declared via DOAJ)
15weeks
Works in OpenAlex
614
Last recorded publication year
2026
h-index
40
i10-index
244
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-01-13
- Added to DOAJ
- 2016-12-06
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 99%
- ORCID iDs in current deposits
- 99%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity4
- Alternate titles
- MSJ experimental, translational, clinicalMSJ ETC
- Source type
- journal
- NLM unique ID (PubMed)
- 101668877
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Multiple Sclerosis Research Studies
- Multiple Sclerosis Research Studies
- Peripheral Neuropathies and Disorders
- Peripheral Neuropathies and Disorders
- Amyotrophic Lateral Sclerosis Research
- Amyotrophic Lateral Sclerosis Research
- Polyomavirus and related diseases
- Polyomavirus and related diseases
Show all subjects (50)
- Systemic Sclerosis and Related Diseases
- Systemic Sclerosis and Related Diseases
- Systemic Lupus Erythematosus Research
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
- Rheumatoid Arthritis Research and Therapies
- Balance, Gait, and Falls Prevention
- Balance, Gait, and Falls Prevention
- Long-Term Effects of COVID-19
- Cerebral Palsy and Movement Disorders
- Long-Term Effects of COVID-19
- Cerebral Palsy and Movement Disorders
- Neurogenesis and neuroplasticity mechanisms
- Neurogenesis and neuroplasticity mechanisms
- Autoimmune Neurological Disorders and Treatments
- Autoimmune Neurological Disorders and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Neuroinflammation and Neurodegeneration Mechanisms
- Sphingolipid Metabolism and Signaling
- Sphingolipid Metabolism and Signaling
- Advanced Neuroimaging Techniques and Applications
- Advanced Neuroimaging Techniques and Applications
- Epilepsy research and treatment
- Epilepsy research and treatment
- Vestibular and auditory disorders
- Vestibular and auditory disorders
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Vaccine Coverage and Hesitancy
- Vaccine Coverage and Hesitancy
- Family Support in Illness
- Cancer survivorship and care
- Pregnancy and Medication Impact
- Ocular Diseases and Behçet’s Syndrome
- Multiple Myeloma Research and Treatments
- Cancer survivorship and care
- SARS-CoV-2 and COVID-19 Research
- Multiple Myeloma Research and Treatments
- Ocular Diseases and Behçet’s Syndrome
- SARS-CoV-2 and COVID-19 Research
- Pregnancy and Medication Impact
- Psoriasis: Treatment and Pathogenesis
Keywords (DOAJ)
- multiple sclerosis
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ